MUTUAL CONFIDENTIAL DISCLOSURE AGREEMENTMutual Confidential Disclosure Agreement • March 4th, 2024 • XOMA Corp • Pharmaceutical preparations
This Mutual Confidential Disclosure Agreement (this “Agreement”), effective as of November 11, 2023 (the “Effective Date”), is entered into by and between Kinnate Biopharma Inc., located at 103 Montgomery Street, Suite 150, The Presidio of San Francisco, San Francisco, CA 94129 (“Kinnate”), and XOMA Corporation, a Delaware corporation located at 2200 Powell Street, Suite 220, Emeryville, CA 94608 (“Collaborator”). Kinnate and Collaborator are each referred to herein as a “Party,” and, collectively, as the “Parties”. In consideration of the covenants and conditions contained herein, the Parties hereby agree to the following:
